Pulmonx
LUNG
115 hedge funds and large institutions have $283M invested in Pulmonx in 2022 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 39 increasing their positions, 19 reducing their positions, and 27 closing their positions.
105% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 19
56% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 27
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
20% more call options, than puts
Call options by funds: $968K | Put options by funds: $805K
11% more funds holding
Funds holding: 104 → 115 (+11)
3.89% less ownership
Funds ownership: 93.64% → 89.75% (-3.9%)
51% less capital invested
Capital invested by funds: $581M → $283M (-$298M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$11.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.8M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.86M |
| 4 |
Morgan Stanley
New York
|
+$2.82M |
| 5 |
JFG
Jefferies Financial Group
New York
|
+$2.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$62M |
| 2 |
TCM
TimesSquare Capital Management
New York
|
-$20.4M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$12.3M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$7.57M |
| 5 |
O
OrbiMed
New York
|
-$7.25M |
LUNG Hedge Fund Activity: Q4 2022 in Review
115 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q4 2022, worth a combined $283M — down 51% from $581M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new LUNG positions and 27 closed out — a net gain of 15 holders — while 39 added to existing stakes and 19 trimmed.
The largest buyer was PFM Health Sciences, adding an estimated $11.9M. The largest seller was Deerfield Management, exiting entirely with an estimated $62M sold.
- 115 institutional investors held Pulmonx (LUNG) as of Q4 2022, up from 104 in Q3 2022.
- Funds reported $283M of Pulmonx stock for Q4 2022, down 51% quarter-over-quarter.
- 42 funds opened new Pulmonx positions in Q4 2022 and 27 closed out, a net change of +15 holders.
- The largest Pulmonx buyer in Q4 2022 was PFM Health Sciences, an estimated $11.9M added.
- The largest Pulmonx seller in Q4 2022 was Deerfield Management, an estimated $62M sold.
Based on aggregated 13F filings for Q4 2022.